⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11327625 | 0.80 | SMN1; SMN2 (0.41) | — | |
| SCHEMBL29141433 | 0.79 | — | — | |
| SCHEMBL27869315 | 0.78 | LMNA (0.43) | — | |
| Ammonia Solution, Strong SCHEMBL28031318 | 0.77 | FDPS (0.37) | — | |
| SCHEMBL2230611 | 0.75 | — | — | |
| SCHEMBL6888639 | 0.75 | MEN1 (0.37) | — | |
| SCHEMBL29141404 | 0.75 | FDPS (0.43) | — | |
| SCHEMBL56859 | 0.73 | — | — | |
| SCHEMBL2773862 | 0.73 | — | — | |
| SCHEMBL4644554 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 582 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115066238-A | Preparation of cannabichromenes and related cannabinoids | 海湾医学公司 | 2022-09-16 | — | — | CN | claimed |
| CN-1922324-B | Bacterial virulence factors and uses thereof | UNIV BRITISH COLUMBIA | 2010-06-09 | — | — | CN | claimed |
| EP-1572074-A4 | STABILIZED SYNTHETIC IMMUNOGEN DELIVERY SYSTEM | UNITED BIOMEDICAL INC (US) | 2008-04-30 | — | — | EP | claimed |
| EP-1465639-A4 | ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME | IRX THERAPEUTICS INC (US) | 2006-05-24 | — | — | EP | claimed |
| EP-1572074-A2 | STABILIZED SYNTHETIC IMMUNOGEN DELIVERY SYSTEM | United Biomedical, Inc. (US) | 2005-09-14 | — | — | EP | claimed |
| US-20050148538-A1 | Adjuvant formulations for bacterial and virus vaccines and method of making same | IRX THERAPEUTICS, INC. | 2005-07-07 | — | — | US | claimed |
| EP-1465639-A2 | ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME | Immuno-RX, Inc. (US) | 2004-10-13 | — | — | EP | claimed |
| EP-1092737-B1 | Catalyst composition for the production of a polyurethane resin, and method for producing a polyurethane resin | TOSOH CORP (JP) | 2003-09-24 | — | — | EP | claimed |
| WO-2003068169-A2 | STABILIZED SYNTHETIC IMMUNOGEN DELIVERY SYSTEM | UNITED BIOMEDICAL INC. (US) | 2003-08-21 | — | — | WO | claimed |
| WO-2003049670-A2 | ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME | IMMUNO-RX, INC. (US) | 2003-06-19 | — | — | WO | claimed |
| US-12042531-B2 | Breast and ovarian cancer vaccines | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2024-07-23 | — | — | US | disclosed |
| CN-114504640-B | Adjuvant containing risedronate zinc-aluminum and application thereof | 厦门大学 | 2024-06-25 | — | — | CN | disclosed |
| US-20240050553-A1 | MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS | Seqirus UK Limited (GB) | 2024-02-15 | — | — | US | disclosed |
| US-11896660-B1 | Reducing hospitalization in elderly influenza vaccine recipients | Seqirus UK Limited (GB) | 2024-02-13 | — | — | US | disclosed |
| US-20240034773-A1 | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-02-01 | — | — | US | disclosed |
| WO-1993011792-A1 | RECOMBINANT BOVINE HERPESVIRUS TYPE 1 POLYPEPTIDES AND VACCINES | UNIVERSITY OF SASKATCHEWAN (CA) | 1993-06-24 | — | — | WO | disclosed |
| EP-0527977-A1 | NEMATODE VACCINE. | BIOTECH AUSTRALIA PTY LTD (AU) | 1993-02-24 | — | — | EP | disclosed |
| US-5151267-A | Bovine herpesvirus type 1 polypeptides and vaccines | UNIVERSITY OF SASKATCHEWAN (CA) | 1992-09-29 | — | — | US | disclosed |
| WO-1992013889-A1 | NEMATODE VACCINE | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1992-08-20 | — | — | WO | disclosed |
| WO-1985000976-A1 | METHOD AND MATERIALS FOR DEVELOPMENT OF IMMUNOLOGICAL RESPONSES PROTECTIVE AGAINST MALARIAL INFECTION | UNIVERSITY OF ILLINOIS (US) | 1985-03-14 | — | — | WO | disclosed |